# Tisento Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tisento-therapeutics

- Industry: Pharmaceuticals
- Headquarters: Cambridge, US
- Total disclosed funding: $81M
- Latest round: Series A (Jul 31, 2023)
- Investors on record: 3

## About

Based in Cambridge, Massachusetts, US, Tisento Therapeutics, Inc. provides novel medicines. In July 2023, the firm raised USD 81 million in Series A funding from investors Sanofi Ventures, Venrock, and, J. Wood Capital, with participation from individual and other investors.

The business creates drugs to treat conditions with high unmet medical needs.

The company plans to use the July 2023 funding to support the phase 2 development of soluble guanylate cyclase stimulator zagociguat.

## Funding rounds

- Series A, Jul 31, 2023, $81M — Venrock, Sanofi Ventures, J. Wood Capital Advisors LLC.

## Investors

- Venrock (https://capitalatlas.ai/funds/venrock) — Series A
- Sanofi Ventures (https://capitalatlas.ai/funds/sanofi-ventures) — Series A
- J. Wood Capital Advisors LLC. — Series A